0.622

1.60% -0.0101

After Hours: .62 -0.002 -0.32%

Mustang Bio Inc (MBIO)

Overview News Price History Financials Why MBIO Down? Discussions Forecast Stock Split

Mustang Bio Inc stock is traded at $0.622, with a volume of 32,397. It is down -1.60% in the last 24 hours and down -17.51% over the past month. Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Previous Close:

$0.6321

Open:

$0.6141

24h Volume:

32,397

Relative Volume:

0.82

Market Cap:

$4.71M

Revenue:

Net Income/Loss:

$-1.92M

P/E Ratio:

-1.5879

EPS:

-0.3917

Net Cash Flow:

$-5.26M

1W Performance:

-3.10%

1M Performance:

-17.51%

6M Performance:

-49.84%

1Y Performance:

-50.24%

1-Day Range:

$0.61

$0.64

1-Week Range:

$0.60

$0.65

52-Week Range:

$0.5306

$7.00

Mustang Bio Inc Stock (MBIO) Company Profile

Name

Mustang Bio Inc

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

(781) 652-4500

Address

95 SAWYER RD, WALTHAM, NY

Employee

Twitter

@Mustang_Bio

Next Earnings Date

2026-05-13

Latest SEC Filings

MBIO's Discussions on Twitter

Compare MBIO vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MBIO Mustang Bio Inc	0.622	4.79M	0	-1.92M	-5.26M	-0.3917
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-18-21	Initiated	BTIG Research	Buy
Oct-02-20	Initiated	B. Riley FBR	Buy
Nov-20-19	Initiated	Cantor Fitzgerald	Overweight
Aug-13-19	Initiated	H.C. Wainwright	Buy
Jun-21-19	Initiated	Cantor Fitzgerald	Overweight
Dec-21-17	Initiated	Oppenheimer	Outperform

View All

Mustang Bio Inc Stock (MBIO) Latest News

May 22, 2026

MBIO Technical Analysis | Trend, Signals & Chart Patterns | MUSTANG BIO INC (NASDAQ:MBIO) - ChartMill

May 22, 2026

May 18, 2026

Mustang Bio (MBIO) Slides -1.27% as Selling Pressure Mounts 2026-05-18AI Expert Picks - Newser

May 18, 2026

What Mustang Bio (MBIO)'s -0.88% Decline Means for Investors 2026-05-18Stock Analysis Community - Newser

May 18, 2026

May 17, 2026

Mustang Bio stock (US62815P1003): restructuring progress keeps spotlight on cash and pipeline - AD HOC NEWS

May 17, 2026

May 16, 2026

Mustang Bio stock (US62815P1003): restructuring moves and Nasdaq relisting plan put focus back on ce - AD HOC NEWS

May 16, 2026

May 15, 2026

Mustang Bio (NASDAQ: MBIO) reports Q1 loss, limited cash and Nasdaq bid-price risk - Stock Titan

May 05, 2026

Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 05, 2026

May 01, 2026

Mustang Bio (MBIO) Stock: Trendline Structure Analysis | Q4 2024: Earnings UnderperformROIC - Newser

May 01, 2026